Advertisement

Topics

Atripla Drug Insights, 2017 [Updated: 30052017] Prices from USD $850

11:44 EDT 21 Jun 2017 | BioPortfolio Reports

DelveInsight Drug Report, Atripla Drug Insights, 2017 highlights the Atripla marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Atripla covering the total sales estimation and also provides the Atripla sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Atripla, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight's Report provides the SWOT analysis for the Atripla.
Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as uptodate as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.
Scope
A review of the Atripla based on information derived from company and industryspecific sources
Coverage of the Marketed data of the Atripla on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
Coverage of the United States Drug Master File US DMF, Active Substance Master File/EU DMF and API Manufactures in China India for Atripla with location details
Patent Expiry Timeline and Exclusivity Details
Route of Synthesis of the API
Global Forecasted Sales Figure to 2018
Qualitative and quantitative assessment of market space
SWOT Analysis
Reasons to buy
Evaluate the marketing status and exclusivity details of Atripla to exploit opportunities for generic drug development opportunities.
Design effective counterstrategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Atripla.
API intelligence over Atripla and gaining primary intelligence over Active Ingredients manufacturers across the globe.
Understanding the chemical route of synthesis of Atripla.
Uncovering opportunities in the rapidly growing the US market
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your MA and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and indepth analysis of the drug's performance
Obtain sales forecast for currently marketed drug for to 2018

Original Article: Atripla Drug Insights, 2017 [Updated: 30052017] Prices from USD $850

NEXT ARTICLE

More From BioPortfolio on "Atripla Drug Insights, 2017 [Updated: 30052017] Prices from USD $850"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...